FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision

FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision

Submitted by admin on June 3, 2016 - 9:52pm
Source: 
Bizjournals.com
News Tags: 
FDA
Sarepta Therapeutics
Janet Woodcock
Duchenne Muscular Dystrophy
eteplirsen
Headline: 
FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision

Do Not Allow Advertisers to Use My Personal information